Indeed, these compounds trigger a down-regulation of the expression of anti-apoptotic proteins (e.g., Bcl-2) and an up-regulation of that of pro-apoptotic proteins (e.g., Bax) in cancer cells, as shown by the biological assays. Here, BCL2 is linked to cancer.